Darlene Donloe
freelance writer/after school teacher
freelance writer/after school teacher
DARLENE DONLOE Journalist/Publicist Darlene Donloe is a results-oriented publicist and seasoned entertainment, automotive, and travel journalist whose work has appeared in People, Ebony, Essence, The Wave Newspaper, LA Watts Times, Los Angeles Sentinel, EMMY, The Daily Breeze, LA Stage Times, This Stage, Black Meetings and Tourism, The Hollywood Reporter, EURweb.com, Compton Herald, Rhythm & Business, Billboard, Grammy magazine and more. An excellent communicator, Donloe’s publicity campaigns include Michael Jackson’s History World Tour, NAACP Image Awards, the Pan African Film Festival, ABC’s Cinderella, Sinbad’s Soul Music Festival, and more. Donloe demonstrated consistent success as an After School teacher and as an adjunct professor at California State University Northridge (CSUN), where she taught public relations.
"I wanted to give the Black community in Los Angeles all the information they would need to be proactive about their health when it comes to Alzheimer’s. No one was talking about it."
The fourth and last in a series of articles on the impact of Alzheimer’s disease on the Black community in Los Angeles.
Aducanumab is the first new drug approved to treat Alzheimer’s disease in nearly 20 years. But some in the medical community were stunned by the approval.
This is the second in a series of articles produced by Darlene Donloe, a 2021 California Fellow, on the impact of Alzheimer’s disease on the Black community in Los Angeles.
“We are still trying to understand how it manifests and how it happens,” said Dr. Emnet Gammada, a clinical geriatric neuro-psychology fellow at the UCLA Semel Institute of Neuroscience and Human Behavior. “What surprises me is how much we know and how much we don’t know.”
Why is the silent epidemic of Alzheimer's more prevalent among Blacks than among whites and other ethnic groups? A journalist sets out in search of answers.